Literature DB >> 15822182

Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs.

Bertil B Fredholm1, Jiang-Fan Chen, Susan A Masino, Jean-Marie Vaugeois.   

Abstract

Adenosine and its receptors have been the topic of many recent reviews. These reviews provide a good summary of much of the relevant literature--including the older literature. We have, therefore, chosen to focus the present review on the insights gained from recent studies on genetically modified mice, particularly with respect to the function of adenosine receptors and their potential as therapeutic targets. The information gained from studies of drug effects is discussed in this context, and discrepancies between genetic and pharmacological results are highlighted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15822182     DOI: 10.1146/annurev.pharmtox.45.120403.095731

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  115 in total

1.  Local disruption of glial adenosine homeostasis in mice associates with focal electrographic seizures: a first step in epileptogenesis?

Authors:  Tianfu Li; Nikki Lytle; Jing-Quan Lan; Ursula S Sandau; Detlev Boison
Journal:  Glia       Date:  2011-09-30       Impact factor: 7.452

2.  Polymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation.

Authors:  S Bodenmann; C Hohoff; C Freitag; J Deckert; J V Rétey; V Bachmann; H-P Landolt
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 3.  Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders.

Authors:  Hyung W Nam; Sally R McIver; David J Hinton; Mahesh M Thakkar; Youssef Sari; Fiona E Parkinson; Phillip G Haydon; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2012-02-06       Impact factor: 3.455

Review 4.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

Review 5.  Glial adenosine kinase--a neuropathological marker of the epileptic brain.

Authors:  Eleonora Aronica; Ursula S Sandau; Anand Iyer; Detlev Boison
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

6.  Identification of zebrafish A2 adenosine receptors and expression in developing embryos.

Authors:  Wendy Boehmler; Jessica Petko; Matthew Woll; Colleen Frey; Bernard Thisse; Christine Thisse; Victor A Canfield; Robert Levenson
Journal:  Gene Expr Patterns       Date:  2008-12-03       Impact factor: 1.224

7.  ENT1 inhibition attenuates epileptic seizure severity via regulation of glutamatergic neurotransmission.

Authors:  Zucai Xu; Ping Xu; Yalan Chen; Jing Liu; Yanke Zhang; Yaodong Lv; Jing Luo; Min Fang; Jun Zhang; Jing Wang; Kewei Wang; Xuefeng Wang; Guojun Chen
Journal:  Neuromolecular Med       Date:  2014-12-10       Impact factor: 3.843

8.  Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice.

Authors:  Hayley A Mattison; Hui Nie; Huiming Gao; Hui Zhou; Jau-Shyong Hong; Jing Zhang
Journal:  J Neuroimmunol       Date:  2013-03-15       Impact factor: 3.478

9.  Adenosine mediated desensitization of cAMP signaling enhances T-cell responses.

Authors:  Ailian Yang; Ashley D Mucsi; Melanie D Desrosiers; Jiang-Fan Chen; Jürgen B Schnermann; Michael R Blackburn; Yan Shi
Journal:  Eur J Immunol       Date:  2010-02       Impact factor: 5.532

Review 10.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.